Nabriva Therapeutics (NBRVF) Q4 2018 Earnings

12MarExpected
Q1 2018
Q2 2018
Q3 2018
Q4 2018
-0.9
-0.7
-0.49
-0.29

Details

Expected EPS
-0.33
Actual EPS
-0.56
Surprise EPS
-0.23
Surprise Percent
+69.7%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -0.56 per share for Q4 2018.

0 Comments

Share your thoughts